As shown in Fig. 4a–d, REV7 expression in REV7 deficient cells rescued TLS efficiency, suggesting that REV7 indeed regulates TLS in 5-FU and oxaliplatin resistant CRC cells. This evidence concerns the gene MAD2L2 and colorectal carcinoma.